Atlas Trials

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4

Clinical trial NCT00002137 · COMPLETED

Trial details

NCT number
NCT00002137
Sponsor
Daiichi Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sarcoma, KaposiHIV Infections

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.